- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01117753
Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
11. juni 2026 opdateret af: Medical University of South Carolina
Stage II Research on Outpatient Treatment for Adolescents With Comorbidity
Adolescent substance abuse results in significant negative outcomes and extraordinary costs for youths, their families, communities, and society.
Moreover, rates of psychiatric comorbidity among substance abusing youth range from 25% up to 82%, and youths with a dual diagnosis are more than twice as costly to treat compared to those with no comorbidity.
The applicant principal investigator recently completed a pilot project funded by the National Institute on Drug Abuse focused on developing and piloting a psychosocial treatment specifically for youth presenting for outpatient treatment with co-occurring substance use and internalizing (i.e., mood and/or anxiety) problems.
Results were promising with the experimental group exhibiting significantly less substance use and more rapid reductions in anxiety and depressive symptoms compared to the control group.
The proposed research is a randomized clinical trial (RCT) to compare the experimental treatment (OutPatient Treatment for Adolescents; OPT-A) to an "active placebo" on key clinical indices from pre-treatment through 18 months.
The proposed RCT (n = 160) employs the treatment manual, quality assurance protocol, and therapist training protocol developed and successfully tested in the pilot study, to evaluate the efficacy of OPT-A for youth referred to outpatient treatment of co-occurring substance use and internalizing problems.
The following outcomes will be evaluated: drug use; mental health; behavioral, school, peer, and family functioning; and consumer satisfaction.
The intervention addresses one of the more prevalent and most challenging, costly, and understudied presenting problems among adolescent outpatients.
If successful, this research could provide a considerable contribution in the treatment field for youth with co-occurring substance use and internalizing disorders.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
140
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater, 29425
- Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
10 år til 17 år (Barn)
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- 10 to 17 years of age
- Residing with at least one adult caregiver who serves as a parent figure
- In need of treatment for a Substance Abuse or Dependence Disorder
- In need of treatment for an Axis I Mood Disorder and/or Anxiety Disorder
Exclusion Criteria:
- Pervasive Developmental Disorder
- Active Psychotic Disorder
- Severe or profound mental retardation
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: OPT-A
OPT-A is an outpatient family-based treatment for co-occurring substance use and internalizing disorders
|
|
|
Aktiv komparator: Treatment as Usual
Treatment as usual in a community based mental health center
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Substance use
Tidsramme: baseline and 1-, 2-, 3-, 6-, 12-, and 18-month follow-up
|
baseline and 1-, 2-, 3-, 6-, 12-, and 18-month follow-up
|
|
Mental Health
Tidsramme: baseline and 1-, 2-, 3-, 6-, 12-, and 18-month follow-up
|
baseline and 1-, 2-, 3-, 6-, 12-, and 18-month follow-up
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Ashli J Sheidow, PhD, Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. juli 2009
Primær færdiggørelse (Faktiske)
1. juni 2014
Studieafslutning (Faktiske)
1. juni 2014
Datoer for studieregistrering
Først indsendt
4. maj 2010
Først indsendt, der opfyldte QC-kriterier
4. maj 2010
Først opslået (Anslået)
5. maj 2010
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
12. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
11. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- MUSC19301.
- 1R01DA025616-01A1 (U.S. NIH-bevilling/kontrakt)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Stof-relaterede lidelser
-
University Hospital, Clermont-FerrandAfsluttetOral Health Related Quality of Life (OHRQoL)Frankrig
-
Riyadh Elm UniversityAfsluttetOral Health Related Quality of Life OHRQoLSaudi Arabien
-
University of MalayaUkendtTranspalatal bue (TPA) | Oral Health Related Quality of Life (OHRQoL) | Oral Health Impact Profile Short Version 14 (OHIP 14) | Ortodontiske smerter | Tredimensionel (3D) ortodontisk enhedMalaysia
-
University of MilanAssociazione Italiana Mowat Wilson (Mowat Wilson Italian Association)Ikke rekrutterer endnuPeriodontale sygdomme | Caries i tænderne | Tandsygdomme | Maloklusion | Kraniofaciale abnormiteter | Tandabnormiteter | Oral slimhindesygdom | Oral Health Related Quality of Life (OHRQoL) | Søvnrelateret vejrtrækningsforstyrrelse | Mowat-Wilson SyndromItalien
-
National Human Genome Research Institute (NHGRI)Children's National Research Institute; Uniformed Services University of...RekrutteringProteus syndrom | PIK3CA Related Overgrowth SpectrumForenede Stater
Kliniske forsøg med OutPatient Treatment for Adolescents (OPT-A)
-
Karolinska InstitutetRekrutteringStofbrugsforstyrrelser | Kriminel adfærdSverige
-
Austin Institute for Clinical ResearchSkinCeuticalsAfsluttet
-
Nitya Jayaram-LindstromRekrutteringDruk | Alkoholbrugsforstyrrelse | Alkohol misbrugSverige
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Chestnut Health SystemsTrukket tilbageAdfærd, vanedannende | Opioid-relaterede lidelser
-
Boehringer IngelheimAfsluttet
-
University of Ljubljana, Faculty of MedicineUniversity Medical Centre Ljubljana; University Maribor; University Psychiatric...RekrutteringIkke-suicidal selvskade | Selvskade | Personlighedsforstyrrelse, Borderline | Forskel, Individuel | Epigenetisk lidelse | Lave om; MentalSlovenien